Psychological factors associated with medication adherence following renal transplantation

Clinical Transplantation

Volumn 21, Issue 6, 2007, Pages 710-715

  Gremigni, Paola ^a   Bacchi, Francesca ^b   Turrini, Chiara ^b   Cappelli, Gianni ^b   Albertazzi, Alberto ^b   Bitti, Pio Enrico Ricci ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Adherence; Coping; Kidney transplantation

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COPING BEHAVIOR; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; PATIENT ATTITUDE; PATIENT AUTONOMY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL WELL BEING; RATING SCALE; SCORING SYSTEM; TREATMENT OUTCOME; TREATMENT REFUSAL;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROGNOSIS; QUALITY OF LIFE;

EID: 35848970583     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00727.x     Document Type: Article

References (26)

1. Will EJ, Johnson JP. Options in the medical management of end-stage renal failure. In: Bradley C, McGee HM eds. Quality of Life following Renal Failure: Psychosocial Challenges Accompanying High Technology Medicine. Amsterdam: Harwood Academic Publishers, 1994.
2. Laederach-Hoffman K, Bunzel B. Non-compliance in organ transplant recipients: A literature review. Gen Hosp Psychiatry 2000: 22: 412.
3. Butler JA, Roderick P, Mullee M, Mason JC, Peveler RC. Frequency and impact of non-adherence to immunosuppressants after renal transplantation: A systematic review. Transplantation 2004: 77: 769.
4. Raiz LR, Kilty KM, Henry ML, Ferguson RM. Medication compliance following renal transplantation. Transplantation 1999: 68: 51.
5. De Geest S, Abraham I, Moons P et al. Late acute rejection and sub clinical noncompliance with cyclosporine therapy in heart transplant patients. J Heart Lung Transplant 1998: 17: 854.
6. Chisholm MA. Issues of adherence to immunosuppressant therapy after solid-organ transplantation. Drugs 2002: 62: 567.
7. Chisholm MA, Lance CE, Mulloy LL. Patient factors associated with adherence to immunosuppressanttherapy in renal transplant recipients. Am J Health-System Pharm 2005: 62: 1775.
8. Myers LB, Midence K. Adherence to Treatment in Medical Conditions. Amsterdam: Harwood Academic Publishers, 1998.
9. Achille MA, Ouellette A, Fournier S, Vachon M, Hébert MJ. Impact of stress, distress and feelings of indebtedness on adherence to immunosuppressants following kidney transplantation. Clin Transplant 2006: 20: 301.
10. Brickman AL, Fins AI. Kidney allograft survival: Relationship to dialysis compliance and other behaviors. Dialysis Transplant 1996: 25: 88.
11. Frazier P, Davis-Ali S, Dahl K. Correlates of noncompliance among renal transplant recipients. Clin Transplant 1994: 8: 550.
12. Kiley DJ, Lam CS, Pollak R. A study of treatment compliance following kidney transplantation. Transplantation 1993: 55: 51.
13. Rodriguez A, Diaz M, Colon A, Santiago-Delpin EA. Psychosocial profile of non-compliant transplant patients. Transplant Proc 1991: 23: 1807.
14. Carver CS, Scheier MF. Situational coping and coping dispositions in a stressful transaction. J Pers Soc Psychol 1994: 66: 184.
15. Christensen AJ. Patient-by-treatment context interaction in chronic disease: A conceptual framework for the study of patient adherence. Psychosom Med 2000: 62: 435.
16. Folkman S, Moskowitz JT. Coping: Pitfalls and promise. Annu Rev Psychol 2004: 55: 745.
17. Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: A theoretically based approach. J Pers Soc Psychol 1989: 56: 267.
18. Sica C, Novara C, Dorz S, Sanavio E. Coping Orientation to Problem Experienced (COPE): Traduzione e adattamento italiano. Bollett Psicol Appl 1997: 223: 25.
19. Sica C, Novara C, Dorz S, Sanavio E. Coping strategies: Evidence for cross-cultural differences? A preliminary study with the Italian version of Coping Orientation to Problem Experienced (COPE). Person Individ Diff 1997: 23: 1025.
20. Dunbar J. Adherence measures and their utility. Control Clin Trials 1984: 5: 515.
21. Fang CY, Daly MB, Miller SM, Zerr T, Malick J, Engstrom P. Coping with ovarian cancer risk: The moderating effects of perceived control on coping and adjustment. Br J Health Psychol. 2006: 11: 561.
22. Isel KC, Reminger SL, Pin-Hsiao C. The negative association of independent personality and medication adherence. J Aging Health 2006: 20: 1.
23. Adams RJ, Smith BJ, Ruffin RE. Patient preferences for autonomy in decision making in asthma management. Thorax 2001: 56: 126.
24. Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development and validation of an immunosuppressant therapy adherence barrier instrument. Nephrol Dial Transplant 2004: 20: 181.
25. Engel G. The need for a new medical model. Science 1977: 196: 129.
26. Schafer-Keller P, Lyon S, Van-Gelder F, De Geest S. A practical approach to promoting adherence to immunosuppressive medication after renal transplantation. Curr Opin Nephrol Hypertens 2006: 15 (Suppl): S1.